“…5 Many clinicians have therefore questioned whether the most common treatment for glioblastoma is appropriate in this apparently weaker population. [6][7][8] In this study, we present data resulting from an analysis of 70 glioblastoma patients who were 60 years old or older. We evaluated their clinical features, immunohistochemical characteristics, treatments, and outcomes to identify factors that are associated with overall survival times, and we further explored whether aggressive treatment is well tolerated in this population.…”